Application no. and date | 20722776.0 (espacenet) (Federated) (European Patent Register), 20200403 | Patent/reg. no. and date | DK/EP 3947682, 20231011 | Publication date | 20220209 | Priority no. and date | US 201962828794 P, 20190403, US 201962843804 P, 20190506, US 201962900126 P, 20190913, US 201962930905 P, 20191105, US 202063000774 P, 20200327 | EP pub. no. and date |
EP 3947682 20220209 | Effective date | | Applicant/owner | Precision Biosciences, Inc., 302 East Pettigrew Street Dibrell Building, Suite A-100
Durham, NC 27701, US | Applicant ref. no. | | Inventor | MARTIN, Aaron, 208 Wild Oak Lane
Carrboro, North Carolina 27510, US, CHATTERTON, Jon E., 14 Highgate Street
Needham, Massachusetts 02492, US, PIRES, Michelle Brenda, 837 Salem Pointe Pl.
Apex , North Carolina 27523, US | Representative | | Opponent | | IPC Class | A61K 35/17 (2015.01) , A61K 39/00 (2006.01) , C07K 14/725 (2006.01) , C12N 15/11 (2006.01) , C12N 15/113 (2010.01) , C12N 15/63 (2006.01) | Title | GENETICALLY-MODIFIED IMMUNE CELLS COMPRISING A MICRORNA-ADAPTED SHRNA (SHRNAMIR) | Int. application no. | US2020026571 | Int. publication no. | WO2020206248 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|